JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area cell cycle plk'

Search results for: 'research area cell cycle plk'

A3794 SB1317

Summary: CDK,JAK and FLT inhibitor

insoluble in H2O; ≥44.87 mg/mL
C3152 ISCK03

Summary: inhibitor of SCF-mediated c-kit activation

≤2 mg/mL
A2033 PQ 401

1 Citation

Summary: IGF1R inhibitor,potent and cell-permeable

insoluble in H2O; ≥17.1 mg/mL
A8603 GNF 2

Summary: Bcr-Abl inhibitor

insoluble in H2O; ≥18.7 mg/mL
A8219 Gefitinib (ZD1839)

3 Citation

Target: EGFR

Summary: Selective EGFR inhibitor

≥22.34 mg/mL
C5553 HNMPA

Summary: cell impermeable tyrosine kinase inhibitor

≤20 mg/mL
A3969 Vatalanib

1 Citation

Target: VEGFR

Summary: VEGFR-1/-2 inhibitor,cell-permeable

≥16.85 mg/mL
N2031 Piceatannol

Summary: p56lck/Syk inhibitor

insoluble in H2O; ≥12.2 mg/mL
A3558 LRRK2-IN-1

1 Citation

Target: LRRK2|DCLK2

Summary: LRRK2 inhibitor,cell-permeable and ATP competitive

≥28.55 mg/mL
A8192 Staurosporine

6 Citation

Summary: Protein kinase inhibitor,potent and cell permeable

insoluble in H2O; insoluble in EtOH; ≥11.66 mg/mL